A study published on 14 October 2026 in the journal PLOS Pathogens has found that herpes simplex virus type 1 (HSV-1) can substantially reshape the behaviour of immune cells in the brain, according to ad-hoc-news.de. The research, led by the University of Colorado Anschutz with other institutions, was carried out in mice and examined how the virus affects microglia, the cells that handle immune defence and maintenance work in the central nervous system.
In the infected animals, the virus stayed confined to specific areas of the brainstem. Within those regions, the microglia displayed markedly elevated activation markers, ad-hoc-news.de reports.
Why it matters
HSV-1 is extremely common. According to World Health Organization figures cited in the coverage, roughly 3.8 billion people under the age of 50 carry the virus — about two-thirds of that age group. Because of that reach, any evidence that the virus disturbs the brain's immune balance draws close attention, particularly given long-running scientific discussion about whether chronic inflammation after viral infection might encourage the formation of harmful protein deposits in nervous tissue. HSV-1 is regularly studied as a possible contributor. There is still no cure for Alzheimer's disease, though approved medicines can influence its course.
A striking response to interferon signals
The most pronounced finding concerned how the cells answered inflammatory cues. In the brain regions touched by the virus, microglia reacted to interferons with unusual intensity: the share of cells showing this response pattern was more than 30 times higher than in animals that received a sham treatment, according to ad-hoc-news.de.
At the same time, genes responsible for the microglia's normal upkeep and protective roles were less active. Beyond the shifted gene expression, the team also detected restructuring of chromatin, the material that packages DNA and helps govern which genes can be switched on.
Niemeyer, a member of the research team, said the pathogen does not merely provoke a short-lived defensive reaction but rewires fundamental molecular programmes in the cells, ad-hoc-news.de reports. Whether those changes persist after the infection itself subsides remains unresolved.
Researchers urge caution on Alzheimer's link
The study's authors were explicit about the limits of their findings. Bruce of the University of Colorado Anschutz, a study author, stressed that the work offers no proof that HSV-1 infection causes Alzheimer's disease, according to ad-hoc-news.de. No Alzheimer's illness was observed in the animals used, and the data therefore do not support recommending preventive antiviral treatment.
The methods also constrain what can be concluded. The analysis was conducted solely in a mouse model, and the animals were euthanised as part of the experiment, so there is no evidence of later neurodegeneration. Whether the signalling changes seen in rodent immune cells occur in the human brain, and to what extent, is a question for future research. German outlets including NDR.de, BR and the Frankfurter Rundschau covered the study alongside ad-hoc-news.de, which also reported that the mouse findings show altered immune cells but no Alzheimer's proof.
What the results do illustrate is how precisely viruses can disrupt immune balance in nervous tissue — while offering no immediate therapeutic guidance for clinical practice. Watch for follow-up work testing whether the microglial changes outlast the infection and whether similar patterns appear in human tissue.
